Drug profile · INN
sotatercept-csrk
WINREVAIR
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
sotatercept-csrk (WINREVAIR) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN sotatercept-csrk
Brand WINREVAIR
Route INJECTION
Formulation INJECTABLE
Frequently asked questions
What is sotatercept-csrk?
sotatercept-csrk (WINREVAIR) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for sotatercept-csrk?
WINREVAIR is a marketed brand name for sotatercept-csrk. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of sotatercept-csrk?
sotatercept-csrk has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.